Go Pro

Craig Hallum's Rating of Tecogen on 4/13/2026

On April 13, 2026, Craig Hallum updated its outlook on Tecogen (NYSEAMERICAN:TGEN) with the action "Initiated Coverage", setting a "Buy" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Craig Hallum

DateCompanyAction
7/31/2026
Cohu, Inc. stock logo
COHU
Cohu
Reiterated Rating
7/31/2026
Silicon Motion Technology Corporation stock logo
SIMO
Silicon Motion Technology
Reiterated Rating
7/31/2026
Phathom Pharmaceuticals, Inc. stock logo
PHAT
Phathom Pharmaceuticals
Reiterated Rating
7/29/2026
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
Reiterated Rating
7/28/2026
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
Boost Price Target
7/28/2026
Maplight Therapeutics, Inc. stock logo
MPLT
Maplight Therapeutics
Reiterated Rating
More Ratings From Craig Hallum